Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to STIMULANTS

Psych Congress Network

Slight Symptom Gains but More Dropouts with Unlicensed Stimulant Doses in ADHD

Psychiatry November 14th 2023

Psych Congress Network

Studies Illustrate Potential of MDMA-, Psilocybin-Assisted Therapies

Psychiatry November 7th 2023

Psych Congress Network

Viloxazine ER Added to Stimulant Treatment for Pediatric ADHD Appears Safe, Effective

Pediatrics September 27th 2023

Psych Congress Network

Understanding the Stimulant Shortage

Psychiatry September 12th 2023

Psychiatrist.com

Emerging Therapies for Attention-Deficit/Hyperactivity Disorder

Internal Medicine September 6th 2023

Medical Professionals Reference (MPR)

DEA, FDA Address Prescription Stimulant Shortage in Joint Letter

Psychiatry August 8th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form